Internal Medicine, Endocrinology, Diabetes, & Metabolism · Mayaguez, PR
NPI
1679854954
Since 2011
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
Edificio la Palma, Calle Peral #14 Suite Ic
Mayaguez, PR, 00677
Phone (787) 644-2002
Medicare paid, 2024
$4,162
46 services
Medicare patients, 2024
18
Average age 76
Drug cost, 2024
$3.5M
12,882 prescriptions
Company payments, 2025
$203
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kyrmarie M Davila was code 99214 (office e&m - established), 40 times for 18 patients. In total Kyrmarie M Davila billed 46 services in 4 codes, and Medicare paid $4,162.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-01-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 40 | 18 | $89.68 | $3,587 |
By year: 2022 $2,966 for 36 services; 2023 $3,973 for 47 services; 2024 $4,162 for 46 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kyrmarie M Davila prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 2,086 prescriptions and refills. In total Kyrmarie M Davila wrote 12,882 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 2,086 | 2,267 | 319 | $105K |
| Glimepiride Generic | 1,162 | 1,292 | 257 | $18K |
| Farxiga Dapagliflozin Propanediol | 853 | 891 | 180 | $524K |
| Metformin Hcl Generic | 778 | 870 | 168 | $3,641 |
| Trulicity Dulaglutide | 677 | 687 | 105 | $679K |
| Ozempic Semaglutide | 597 | 646 | 97 | $584K |
| Jardiance Empagliflozin | 472 | 502 | 96 | $309K |
| Humalog Kwikpen U-100 Insulin Lispro | 410 | 643 | 117 | $74K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 405 | 823 | 135 | $41K |
| Pen Needle Pen Needle, Diabetic | 364 | 371 | 86 | $6,301 |
| Januvia Sitagliptin Phosphate | 305 | 314 | 77 | $181K |
| Humulin 70/30 Kwikpen Insulin Nph Hum/Reg Insulin Hm | 234 | 362 | 57 | $34K |
| Glipizide Generic | 209 | 236 | 45 | $2,803 |
| Tradjenta Linagliptin | 206 | 208 | 46 | $111K |
| Ultra-Fine Nano Pen Needle Pen Needle, Diabetic | 194 | 217 | 52 | $9,754 |
Brand drugs: 8,035 claims; generic drugs: 3,460 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kyrmarie M Davila $203 ($203 in general payments such as food, travel and fees) from 5 companies. The largest payer was Amgen Inc. with $68.99.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.